NCT06647992

Brief Summary

This study was designed as a randomized controlled experimental study to examine the effect of the 'Nurse Navigation Program' on cervical cancer screening behaviors (Human Papilloma Virus (HPV) DNA screening test and/or pap smear test) and health beliefs about cervical cancer screening in women aged 30-65 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 13, 2024

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

October 10, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 18, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
Last Updated

June 9, 2026

Status Verified

June 1, 2026

Enrollment Period

7 months

First QC Date

October 10, 2024

Last Update Submit

June 7, 2026

Conditions

Keywords

Uterine Cervical NeoplasmsPatient NavigationTranstheoretical ModelHealth behavior

Outcome Measures

Primary Outcomes (1)

  • Health Belief Model Scale for Cervical Cancer and Pap Smear Test: Psychometric testing

    Health Belief Model Scale for Cervical Cancer and Pap Smear Test: Psychometric testing consists of 35 items grouped into five subscales. 1. Pap smear Benefit (items 18.-22.) and Health Motivation (items 11.-14.) subscales 2. Pap smear Perception of obstacle (items 23-36) subscale, 3. Cervical cancer severity perception (Items 4-10) subscale, 4. Cervical cancer sensitivity perception (Items 1 - 3) subscale, 5. Health Motivation subscale (items 15-17) A 5-point Likert scale ranging from 1 to 5 - "strongly disagree" (1), "disagree" (2), "undecided" (3), "agree" (4), "strongly agree" (5) - was used to assess the scale. Each dimension of the scale is evaluated separately and not combined into a single total score. For each individual, as many points are obtained as the number of sub-dimensions.

    Pre-test, 3rd month post-test, 6th month post-test

Study Arms (2)

Intervention group- Nurse Navigation Program

EXPERIMENTAL

The standard education and information booklet will be applied to both the experimental and control groups. Nurse navigation program will be applied to the experimental group. Within the navigation program, HPV DNA and Pap Smear Test Training and Counseling, Nurse Managed Telephone Support Line, Reminder Telephone Message, Transtheoretical Model and Motivational Interviews will be applied to individuals. Health Belief Model Scale for Cervical Cancer and Pap Smear Test: Psychometric testing is planned to be applied to both groups before and after the intervention in terms of outcome variables at 3 and 6 months.

Behavioral: Nurse Navigation Program

control group- Standardised Education

NO INTERVENTION

It was planned to give "Cervical Cancer Education and Information Booklet" to the women in the control group about cervical cancer. Health Belief Model Scale for Cervical Cancer and Pap Smear Test: Psychometric testing was planned to be applied before and after the standard education and booklet in terms of outcome variables at 3 and 6 months.

Interventions

It is planned to provide "Cervical Cancer Education and Counseling" to women in the experimental group about cervical cancer. Training and counseling is planned to be implemented face to face. An information booklet will be given to the experimental group. After 30 and 60 days after the training and counseling given to the experimental and control groups, it was planned to provide online (WhatApp) training and counseling to the patients in the experimental group: Participants will be given a contact number that they can reach during the day when they want to receive counseling about HPV-DNA or Pap smear. Interviews will be scheduled between 08.00-20.00. Individuals who are not screened will receive a reminder message by phone on the 45th and 75th day. Transtheoretical Model In the study, interventions will be planned for the experimental group according to the stages of the transtheoretical model. The researcher will conduct motivational interviews with the individuals.

Intervention group- Nurse Navigation Program

Eligibility Criteria

Age30 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged between 30 and 65 years, able to use the WhatsApp application, not undergoing regular cervical cancer screening, with no history of gynecological cancer, currently or previously sexually active, and voluntarily willing to participate in the study.

You may not qualify if:

  • Women who had a current diagnosis or history of gynecological cancer, were undergoing regular cervical cancer screening, were unable to use the WhatsApp application, had never been sexually active, or did not provide voluntary consent to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saglık Bilimleri University

Istanbul, Üsküdar, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Uterine Cervical NeoplasmsHealth Behavior

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesBehavior

Study Officials

  • Turkan Ozdas

    Saglık Bilimleri University

    PRINCIPAL INVESTIGATOR
  • Donmez Elif

    Saglık Bilimleri University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Oncology Nursing PhD Student

Study Record Dates

First Submitted

October 10, 2024

First Posted

October 18, 2024

Study Start

September 13, 2024

Primary Completion

March 30, 2025

Study Completion

March 30, 2025

Last Updated

June 9, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations